会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Methods of Screening for LTRPC7 Modulators
    • LTRPC7调制器筛选方法
    • US20090098546A1
    • 2009-04-16
    • US12128471
    • 2008-05-28
    • Reinhold PennerAndrea Fleig
    • Reinhold PennerAndrea Fleig
    • C12Q1/68G01N33/53
    • G01N33/6872C07K14/705G01N2500/04
    • The present invention relates to the identification and isolation of a novel family of ATP regulated calcium transmembrane channel polypeptides designated herein as “LTRPC7” (Long Transient Receptor Potential Channel). Channels comprising these polypeptides close in response to concentrations of cytoplasmic ATP in the millimolar range, are subject to inhibition by high intracellular levels of calcium and/or magnesium, and do not respond to depletion or reduction in intracellular calcium stores. The invention further relates to the methods of utilizing LTRPC7 for binding, and the methods for modulating LTRPC7 activity and for measuring LTRPC2 permeability. The invention further relates to the methods of modulating expression of LTRPC7.
    • 本发明涉及鉴定和分离本文称为“LTRPC7”(长瞬态受体电位通道)的ATP调节的钙跨膜通道多肽的新家族。 包含这些多肽的通道在毫微克范围内响应细胞质ATP的浓度而接近的细胞受到钙和/或镁的高细胞内水平的抑制,并且不对细胞内钙储存物的消耗或减少作出反应。 本发明还涉及使用LTRPC7进行结合的方法,以及调节LTRPC7活性和测量LTRPC2渗透性的方法。 本发明还涉及调节LTRPC7表达的方法。
    • 8. 发明授权
    • Methods of screening for LTRPC7 modulators
    • 筛选LTRPC7调节剂的方法
    • US08580525B2
    • 2013-11-12
    • US12128471
    • 2008-05-28
    • Reinhold PennerAndrea Fleig
    • Reinhold PennerAndrea Fleig
    • G01N33/567C12N5/22
    • G01N33/6872C07K14/705G01N2500/04
    • The present invention relates to the identification and isolation of a novel family of ATP regulated calcium transmembrane channel polypeptides designated herein as “LTRPC7” (Long Transient Receptor Potential Channel). Channels comprising these polypeptides close in response to concentrations of cytoplasmic ATP in the millimolar range, are subject to inhibition by high intracellular levels of calcium and/or magnesium, and do not respond to depletion or reduction in intracellular calcium stores. The invention further relates to the methods of utilizing LTRPC7 for binding, and the methods for modulating LTRPC7 activity and for measuring LTRPC2 permeability. The invention further relates to the methods of modulating expression of LTRPC7.
    • 本发明涉及鉴定和分离本文称为“LTRPC7”(长瞬态受体电位通道)的ATP调节的钙跨膜通道多肽的新家族。 包含这些多肽的通道在毫微克范围内响应细胞质ATP的浓度而接近的细胞受到钙和/或镁的高细胞内水平的抑制,并且不对细胞内钙储存物的消耗或减少作出反应。 本发明还涉及使用LTRPC7进行结合的方法,以及调节LTRPC7活性和测量LTRPC2渗透性的方法。 本发明还涉及调节LTRPC7表达的方法。